微小RNA-605-3p通过上调EZH2抑制前列腺癌的恶性进展。
MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
作者信息
Pan M-Z, Song Y-L, Gao F
机构信息
Department of Urology Surgery, The Seventh People's Hospital of Jinan, Jinan, China.
出版信息
Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2156. doi: 10.26355/eurrev_202103_25197.
We detected some serious inaccuracies and mistakes. Therefore, the article "MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2, by M.-Z. Pan, Y.-L. Song, F. Gao, published in Eur Rev Med Pharmacol Sci 2019; 23 (20): 8795-8805-DOI: 10.26355/eurrev_201910_19274-PMID: 31696466" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/19274.
我们发现了一些严重的不准确之处和错误。因此，发表于《欧洲医学与药理学评论》2019年；23（20）：8795 - 8805 - DOI: 10.26355/eurrev_201910_19274 - PMID: 31696466，题为“MiR - 605 - 3p通过上调EZH2抑制前列腺癌的恶性进展，作者M.-Z. Pan、Y.-L. Song、F. Gao”的文章已被撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/19274
Zotero 插件